Essential drugs
Lunde, P.K.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 109(11): 1191-1192
1989
ISSN/ISBN: 0029-2001 PMID: 2734750 Document Number: 328797
Document emailed within 1 workday
Related Documents
Fattorusso, V. 1977: Essential drugs Annali Dell'istituto Superiore di Sanita 13(4): 875-885Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Kingma, S. 1984: Getting essential drugs to the people Philippine Journal of Nursing 53(2): 32-36
Golos, M.; Buchbauer, G. 2015: Essential oils and their influence on the actions of drugs: some examples Medizinische Monatsschrift für Pharmazeuten 38(8): 290-296
Koster, M. 1980: Different patterns in essential hypertension and possible choice of antihypertensive drugs Archives Internationales de Pharmacodynamie et de Therapie Suppl: 227-232
Laing, R.; Ruredzo, R. 1989: The essential drugs programme in Zimbabwe: new approaches to training Health Policy and Planning 4(3): 229-234
Foster, S. 1991: Supply and use of essential drugs in sub-Saharan Africa: some issues and possible solutions Social Science and Medicine 32(11): 1201-1218
Fossati, C. 1980: Therapy of essential arterial hypertension. IV. Drugs with peripheral sympathetic action La Clinica Terapeutica 93(4): 457-479
Huff-Rousselle, M.; Simooya, O.; Kabwe, V.; Hollander, I.; Handema, R.; Mwango, A.; Mwape, E. 2007: Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond Global Public Health 2(2): 184-203
Jeck, T.; Edmonds, D.; Mengden, T.; Schubert, M.; Renz, I.; Weisser, B.; Vetter, W. 1992: Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol International Journal of Clinical Pharmacology Research 12(3): 139-148
Bhatia, J.; Mahajan, P.; Sikka, M.; Kalra, O.P. 2001: Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension Indian Journal of Medical Sciences 55(9): 491-494
Nhachi, C.F.; Kasilo, O.J. 1993: Perception of hospital pharmacists/dispensing personnel of the essential drugs concepts (EDC) in Zimbabwe East African Medical Journal 70(2): 94-97
Kasilo, O.J.; Mwaluko, G.M. 1992: The essential drugs in Tanzania: a ten year (1979-1988) review following the Alma Ata declaration East African Medical Journal 69(5): 288-293
Muralidhar, V.; Sharma, A. 1996: Carcinoid crisis during a partial hepatic resection; lack of essential drugs: a cause for concern in the tropics Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 17(1): 26-29
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Rahn, K.H. 1980: The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
Breckenridge, A. 2003: Debate that "this house believes the essential drug concept hinders the effective deployment of drugs in developing countries". Introduction Transactions of the Royal Society of Tropical Medicine and Hygiene 97(1): 1
Wibulpolprasert, S. 2008: The need for guidelines and the use of economic evidence in decision-making in Thailand: lessons learnt from the development of the national list of essential drugs Journal of the Medical Association of Thailand 91 Suppl. 2: S1-S3